Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

KPTI holding history

Karyopharm Therapeutics Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KPTI overviewAll 13F holders of KPTIFull Q2 2026 holdings

Shares (Q2 2026)
42,952
Value
$419.6K
% of portfolio
0.2%
Quarters held
21
Since Q1 2021
Holdings of KPTI by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,952$419.6K0.2%−41,000−48.8%ReducedHolders
Q1 202683,952$467.6K0.3%+83,952NewHolders
Q4 20250$00.0%−27,985−100.0%Sold outHolders
Q3 202527,985$183.0K0.1%00.0%UnchangedHolders
Q2 202527,985$120.6K0.1%00.0%UnchangedHolders
Q1 202527,985$104.7K0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q4 2024419,832$283.9K0.2%−50,000−10.6%ReducedHolders
Q3 2024469,832$390.0K0.3%00.0%UnchangedHolders
Q2 2024469,832$407.6K0.4%00.0%UnchangedHolders
Q1 2024469,832$709.4K0.6%00.0%UnchangedHolders
Q4 2023469,832$406.4K0.3%−102,000−17.8%ReducedHolders
Q3 2023571,832$766.3K0.7%+280,500+96.3%AddedHolders
Q2 2023291,332$521.5K0.4%00.0%UnchangedHolders
Q1 2023291,332$1.13M0.9%00.0%UnchangedHolders
Q4 2022291,332$991.0K0.7%+22,000+8.2%AddedHolders
Q3 2022269,332$1.47M1.0%00.0%UnchangedHolders
Q2 2022269,332$1.22M0.9%00.0%UnchangedHolders
Q1 2022269,332$1.99M1.4%+23,332+9.5%AddedHolders
Q4 2021246,000$1.58M1.0%00.0%UnchangedHolders
Q3 2021246,000$1.43M1.0%+16,000+7.0%AddedHolders
Q2 2021230,000$2.37M1.4%00.0%UnchangedHolders
Q1 2021230,000$2.42M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.